Plan Your ACC.26 Using the EP Section Events Guide

March 17, 2026

Upcoming Event

Don’t miss Electrophysiology (EP) Section events at ACC.26! Check out the ACC.26 EP Events Guide to get a curated list of can’t-miss sessions and events. For a full list of all EP sessions, go to the online program planner.

ACC Webinar: ACC.26 EP Highlights: What Clinicians Need to Know

March 16, 2026

Featured Webinar

Join ACC's Electrophysiology (EP) Member Section on Thursday, April 2 at 7 p.m. ET for a webinar reviewing EP highlights from ACC.26. Experts will review results from key trials, including CHAMPION-AF, and how they will influence practice. Learn more and register.

THT 2026 Studies Highlight Technological, Therapeutic Advances in HF Care

March 16, 2026

JACC Family of Journals

Recent studies presented at Technology and Heart Failure Therapeutics (THT) 2026 and simultaneously published in JACC, JACC: Heart Failure and JACC: Cardiovascular Interventions highlight advances in heart failure (HF) treatment:

• Sotatercept improves exercise tolerance in pulmonary arterial hypertension through mechanisms beyond the pulmonary vasculature, including increased hemoglobin.
• Baseline and early post‑procedure N-terminal pro-B-type natriuretic peptide levels help predict two‑year mortality or HF hospitalization after tricuspid edge-to-edge repair, offering a potential tool for risk stratification.
• Physician‑directed patient self‑management using ambulatory inferior vena cava‑based congestion monitoring proved feasible, increased timely interventions and showed favorable safety and clinical signals, supporting further evaluation in a randomized trial.